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Aim: To investigate the effects of polypharmacy and vitamin D levels on the risk of falls in the elderly. 
Methods: The prospective study included 201 patients (F/M: 155/46) aged 65 years and older who presented 
with nonspecific musculoskeletal pain. The demographic and laboratory data of the patients, as well as the 
results of a single leg stance test (SLST), a timed up and go (TUG) test and levels of vitamin D were recorded.  
Results: The percentage of patients with polypharmacy is 15.9 percent and 29.4 percent used no medications. 
The SLST score was the lowest and the TUG test score was significantly higher in the polypharmacy group 
(p<0.05). Vitamin D levels were significantly higher in patients with normal SLST times than those with 
abnormal SLST times (p<0.05). The risk of falls was significantly higher among patients with a previous 
history of a fall (p<0.05). Polypharmacy and the female gender appeared as the most significant factors 
affecting the risk of falls (p<0.05), while vitamin D level was found to have no effect (p>0.05).  
Conclusion: Medical therapies for the treatment of diseases in the elderly should have a rational basis, as this 
may reduce falls, particularly in the elderly population, that can have serious consequences, and may even lead 
to death. 
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Introduction 
The aging global population has brought 
problems related to health services, the 
economy and the environment. Falls among the 
elderly may result from impaired vision, 
vestibular and proprioceptive sensation, and 
muscle strength [1]. Falls can occur as a result 
of distruption to postural balance, which 
ensures that the center of gravity remains in 
contact with the support surface, and can cause 
serious mortality and morbidity [2]. Among 
elderly people aged 65 years and older, 
approximately 13 percent have a balance 
disorder and one-third experience at least one 
fall per year [3]. In case of fall, 20 percent of 
people are admitted to hospital and 10 percent 
may have soft tissue or joint damage, or even 
fractures [4]. Studies have shown that there are 
many factors other than age that increase the 
risk of falls, these include multiple chronic 
disorders (musculoskeletal disorders, 
neurologic and psychotic disorders, diabetes 
mellitus, etc.), polypharmacy and vitamin D 
deficiencies [5,6].  
The most common definition of polypharmacy 
in studies refers to the use of four or more 
medications in one day [7]. Medications can 
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have side effects related to the metabolic state 
already affected by aging, and these side effects 
may increase the risk of falls. Researchers can 
be divided into two different groups, based on 
the results of a meta-analysis on this subject. 
While some emphasize the importance of a 
large number of medications, others place more 
emphasis on the type of medications used 
(antiaritmic, antihypertensive and antiepileptic 
drugs, etc.) [8]. There are also studies indicating 
that polypharmacy contributes two times more 
to falls than any other factor [9], while other 
studies have suggested that the use of at least 
one drug that contributes to falls has a more 
significant impact [10]. 
Epidemiological studies have identified a 
possible association between vitamin D level 
and risk of falling [11], although there is 
controversy between such studies. Some more 
recent studies suggest that vitamin D regulates 
muscle development, its deficiency may cause 
muscle weakness and may be associated with 
an increased risk of falls in the elderly [12]. 
Other studies, in contrast, found no association 
between falls and vitamin D level [13]. 
Studies on polypharmacy and vitamin D levels 
have given conflicting results in terms of their 
effects on falls. The aim of this study is to 
investigate whether polypharmacy and vitamin 
D levels affect the risk of falls in any way. 
 
Materials and Methods 
Patients aged 65 years and older who were 
hospitalized for nonspecific muscle pain within 
the previous year were prospectively studied. 
Ethical approval was obtained from Clinical 
Trials Ethical Board at Bolu Abant Baysal 
University (Date and decision number: 
2015/64). Demographic data of the patients, 
laboratory and X-ray results, history of falls in 
the last year, comorbid diseases and the number 
of medications being used were recorded. 
Patients  with total blood count, erythrocyte 
sedimentation rate and C-reactive protein levels 
within normal ranges are included, whereas 
those with scoliosis, degenerative and 
inflammatory joint disease in the lower 
extremity, total hip and/or knee prosthesis, 
neuromuscular disease, dementia, mental 
retardation, traumatic brain damage, 
cerebrovascular disease, spinal cord injury, 
severe cardiovascular disease, visual 
impairment, and patients with alcohol and drug 
addictions were excluded from the study. 
Polypharmacy was defined as the use of four or 
more medications,  and vitamin D deficiency 
was defined as 25(OH)D3 levels below 30 
ng/ml, while values of 30 ng/ml and higher 
were defined as normal [14]. Single-leg stance 
test (SLST) and the timed up and go (TUG) test 
results were evaluated to determine the risk of 
falling. In the SLST, patients were instructed to 
stand on one leg hands facing down by their 
sides. The test was terminated when the 
patient’s foot touched the ground, changed 
position or received support from the ground. 
The test lasts a maximum of 30 seconds and is 
performed three times, with the best 
performance recorded for analysis. A test result 
of 5 seconds or less indicates a balance 
disorder. In the TUG test, patients are instructed 
to get up from a chair without support, walk 
three meters and turn back, return to the chair, 
and then sit down. A test result of 14 seconds or 
higher indicates a balance disorder.  
Statistical analysis  
The statistical analysis was performed using the 
SPSS 22.0 statistical software (IBM Corp., 
Armonk, NY, US). A Shapiro-Wilk Test was 
used to determine whether the data was 
normally distributed. Data with a normal 
distribution was expressed as mean ± standard 
deviation, while data without normal 
distribution was expressed as a median (min, 
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max). Paired correlations were evaluated from 
a Spearman's rank correlation coefficient, and a 
Mann-Whitney U test was used to evaluate the 
relationship between two independent groups, 
A Kruskal-Wallis test was used to evaluate the 
relationship between more than two 
independent groups, a Chi-Square test to 
evaluate the relationship between categorical 
variables, and the proportion of the categorical 
groups was expressed as a percentage (%). The 
effects of the quantitative and categorical data 
on the other groups were evaluated by logistic 
regression analysis. A p value of <0.05 was 
considered statistically significant. 
 
Results  
The study included 201 patients (F/M: 155/46) 
with a mean age of 68.6 (65–75) years (Table 
1). It was found that15.9 percent of the study 
patients used polypharmacy and 29.4 percent 
were not on any medications. 51.7 percent of 
the patients using medication used 
antihypertensive drugs, 6.0 percent used 
antidiabetic and 2.5 percent used antipsychotic 
medications. The SLST duration was normal in 
49.3 percent and the TUG test was normal in 
60.7 percent of the participants. There was a 
significant negative correlation between the 
SLST and TUG test results (r:-256, p<0.05), 
and also a significant correlation between the 












SLST duration was observed to decrease with 
the increasing number of medications, and 
SLST durations were found significantly 
shorter in the polypharmacy group  compared 
to patients  who received less than four 















Concomitant use of more than one drug was 
more common in females then males. Of the 
study group, 29.8 percent had a remarkable 
history of falls, and the falling rate was 
significantly higher in females (88.3%) than in 
males (72.3%) (p<0.05). SLST times were 
significantly lower and TUG times were higher 
in patients with a history of falling compared to 
those without a history of falling (p<0.05), 













Table 1. Demographic values. 
Variables Median Min. Max. 
Age (year) 68,6   65    75 
Body mass index 
(kg/m2) 
25,9 22,1 27,5 
Vitamin D 
(IU/ml) 




12,6 4 21 
Time up & go test 
(TGT) (sn) 






Figure 1. Relationship between SLST duration and 
number of drugs. 
 
Figure 2. Relationship between falls and SLST 
duration. 
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SLST durations were significantly shorter and 
TUG durations were longer in patients using 
antipsychotic medications when compared to 
those who did not use antipsychotic 
medications (p<0.05). Only the SLST time was 
significantly shorter in patients on antidiabetics 
when compared to patients who did not take 














SLST durations were significantly lower and 
TUG durations were higher in female patients 
compared to male patients (p<0.05). There was 
a significant positive correlation between 
vitamin D levels and SLST duration (r: 0.212 
p<0.05), and vitamin D levels were 
significantly higher in patients with normal 
SLST times than those with abnormal SLST 
times (p<0.05). In the evaluation of the factors 
affecting the risk of falls, polypharmacy 
followed by TUG time and female gender had 














Showing an increasing prevalence with 
increased life expectancy, approximately 30–40 
percent of elderly people aged 65 years and 
older experience falls, and 50 percent of these 
patients have a history of recurrent falls. 
Preventive measures must be taken due to the 
increased morbidity and mortality risk in the 
elderly after falling [15]. In population-based 
studies, researchers have reported rates of 16.5 
percent, 21.8 percent and 45.4 percent for 
recurrent falls [4,5,9] compared to the recurrent 
falling rate of 29.9 percent in the this study. 
Studies have also found that females are three 
times more likely to experience falls than men, 
which has been attributed to the difference in 
muscle mass due to gender, the use of high 
heels in women and more common household 
accidents among women. In the present study, 
recurrent falls were twice as common in women 
as in men [7].  
Due to the potentially serious consequences of 
falls, studies have focused on determining risk 
factors and in developing strategies to prevent 
 
 
Figure 3. Relationship between falls and TUG 
duration. 
 
Figure 4. Relationship between antidiabetic 
use and SLST duration. 
 
Table 2. The factors effecting falls.  









3,66 1,08 12,42 
Time up & 
go test (sn) 
1,24 1,10 1,39 
Women 
gender 
0,35 0,13 0,96 
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falls. Simply, falls occur when an individual 
loses his/her balance, and therefore balance 
assessments are the most important and 
relevant in the prevention of falls. Researchers 
have developed several tests for balance 
assessment, including the SLST and TUG tests 
which observe static and dynamic balance [16]. 
A three-year study involving 316 volunteers 
established SLST time as a risk factor for falls, 
and reported an association between recurrent 
falls, whereas another study involving patients 
with a mean age of 73.6 years reported no such 
relationship [17]. In the present study, the mean 
age of the study population was 68.6 years and 
SLST times were significantly lower in patients 
with a history of recurrent falls. Studies 
involving patients aged 65 years and above 
reported a relationship between TUG time and 
age, and suggested that a high TUG time is 
associated with recurrent falls [10]. The present 
study found no significant relationship between 
TUG time and age, whereas a significant 
relationship was noted between TUG time and 
repeated falls. 
Hypertension, diabetes, and neurological and 
psychological disorders are the leading 
comorbid conditions that increase in parallel 
with aging. In recent years, there has been a 
linear increase in the use of antihypertensive, 
antidiabetic and antipsychotic drugs among the 
increasing elderly population [10]. Kojima et 
al. [9] evaluated the two-year fall rate in 
patients older than 65 years taking medication 
for chronic diseases, and they found that the 
concurrent use of multiple medications 
increased the prevalence of falls. In a 
longitudinal study, Dhalwani et al. [18] 
reported a rate of falls of 18 percent in subjects 
who were on four or more medications, and 50 
percent in subjects on 10 of more medications. 
There are many studies reporting a significant 
negative correlation between the number of 
medications and SLST time, whereas other 
studies have found that certain types of 
medication (antihypertensive, antidiabetic, 
antipsychotic) are more likely to increase falls 
[8]. These studies define such medications as 
drugs that increase the risk of falls. The rate of 
polypharmacy was found to be as high as 79.9 
percent in a study involving 293 elderly hospice 
patients, and polypharmacy was found to 
increase the rate of fall-related injuries 4.5 
times [4], although another study reported that 
polypharmacy increases the rate of injury 1.5 
times [3]. In the present study, the risk of falls 
increased 3.6 times. Studies have also shown 
that the use of medications that increase the risk 
of falls (antihypertensive, antidiabetic, 
antipsychotic) bring about a further increase in 
risk when combined with polypharmacy. In a 
prospective study evaluating patients aged 55 
years and above who were admitted to hospital, 
Ziere et al. [7] reported an increased risk of falls 
among patients who used four or more 
medications, and stated that the use of even a 
single medication increased the rate of falls in 
the presence of a drug that increased the risk of 
falls. Laflamme et al. [19] retrospectively 
evaluated patients aged 65 years and above who 
presented with fall-related injuries, and found 
that the risk of falls increased in the presence of 
polypharmacy, although an increased risk of 
falls was identified in the presence of 
medication use that increased the risk of falls 
regardless of the number of medications. RA 
balance study involving patients with 
hypertension found that the use of 
antihypertensive medications had a negative 
effect on balance [20], while the present study, 
in contrast, found no such effect of 
antihypertensive medication use on the risk of 
falls, the rate of which was 73 percent in the 
polypharmacy group. This is attributed to the 
widespread use of antihypertensive therapies, 
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while similar studies have found that patients 
on antidiabetic and antipsychotic medication 
are more likely to experience falls. Similarly, 
the present study found a significantly higher 
rate of antidiabetic and antipsychotic 
medication use in the polypharmacy group, 
indicating its negative effect on balance. Taking 
drug use into consideration rationally would 
prevent possible drug side effects and would 
reduce their negative effects on the risk of falls.  
The musculoskeletal system is another body 
system that affects balance. Maintaining 
sufficient level of minerals and vitamins in the 
body has been found to be associated with 
overall health status and balance mechanisms, 
and vitamin D is one of the more important 
vitamins in this regard [13]. Vitamin D acts as 
a precursor hormone analogue, and plays an 
important role in several important 
mechanisms, including calcium imbalance 
[13]. Studies have found impaired balance and 
muscle development in patients with vitamin D 
deficiency, indicating that vitamin D levels 
have a positive effect on physical performance 
in individuals aged 65 years and above [6]. It 
has been reported that elderly people with 
normal vitamin D levels perform better than 
people with vitamin D deficiency, with vitamin 
D levels below 24 ng/ml in particular have 
dramatic negative effects on balance, leading to 
recommendations for careful attention to 
vitamin D levels [21]. SLST times were higher 
in individuals aged 60 years and older with 
normal vitamin D levels than patients with 
lower levels [13], and the present study found 
significantly lower TUG durations in patients 
with vitamin D deficiency, although no effect 
of vitamin D was observed on falls. 
The strengths of the study includes the use of 
extensive exclusion criteria, the limited age 
range of the patients and the evaluation of the 
reviewed data by a specialist. The limitations of 
the study include small number of patients, 
single-center study design, and lack of data on 
sociocultural aspect of the study patients.  
Organic factors must be evaluated in 
conjunction with environmental factors when 
evaluating fall risk in the elderly. There have 
been many studies investigating the concurrent 
use of multiple medications in patients with 
falls, and in the present study, patients were 
evaluated with tests that are used to evaluate 
predispositions to falls, and the findings may be 
relevant in efforts to come up with measures to 
decrease the risk of falls. The number of 
medications used by elderly patients may be 
reduced through lifestyle modifications, and the 
type and number of currently used medications 
must be taken into consideration when 
prescribing new medications. Monitoring 
vitamin D levels from early ages, and 
maintaining optimal levels may be important in 
maintaining a good neuromuscular structure in 
advanced ages. More comprehensive studies 
involving larger populations should be 
conducted. 
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